BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18412092)

  • 1. Innovations in bifurcations.
    Colombo A
    Catheter Cardiovasc Interv; 2008 May; 71(6):E7-8. PubMed ID: 18412092
    [No Abstract]   [Full Text] [Related]  

  • 2. IVUS in bifurcation stenting: what have we learned?
    Trabattoni D; Bartorelli AL
    EuroIntervention; 2010 Dec; 6 Suppl J():J88-93. PubMed ID: 21930498
    [No Abstract]   [Full Text] [Related]  

  • 3. The AUTAX (Austrian Multivessel TAXUS-Stent) registry: another useful registry on stented angioplasty for multivessel disease?
    Wijns W
    JACC Cardiovasc Interv; 2009 Aug; 2(8):728-30. PubMed ID: 19695540
    [No Abstract]   [Full Text] [Related]  

  • 4. When are two stents needed? Which technique is the best? How to perform?
    Latib A; Moussa I; Sheiban I; Colombo A
    EuroIntervention; 2010 Dec; 6 Suppl J():J81-7. PubMed ID: 21930497
    [No Abstract]   [Full Text] [Related]  

  • 5. Bifurcation disease: what do we know, what should we do?
    Latib A; Colombo A
    JACC Cardiovasc Interv; 2008 Jun; 1(3):218-26. PubMed ID: 19463303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravascular ultrasound guidance may be an option for coronary interventions.
    Pawlowski T; Gil R
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):750-1. PubMed ID: 18942136
    [No Abstract]   [Full Text] [Related]  

  • 8. Advanced Bifurcation Systems' mother-daughter platform.
    Khorsandi M; Abizaid A; Dani S; Bourang H; Costa R; Kar S; Makkar R
    EuroIntervention; 2010 Dec; 6 Suppl J():J165-8. PubMed ID: 21930486
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary for "Comparison of drug eluting stents with bare metal stents in unselected patients with acute myocardial infarction".
    King SB;
    Catheter Cardiovasc Interv; 2008 May; 71(6):E1-2. PubMed ID: 18412088
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward better stratification of patients with left main disease: value of clinical and angiographic-derived risk scores.
    Applegate RJ
    JACC Cardiovasc Interv; 2011 Mar; 4(3):298-9. PubMed ID: 21435607
    [No Abstract]   [Full Text] [Related]  

  • 11. The Cappella Sideguard™ stent.
    Latib A; Chieffo A
    EuroIntervention; 2010 Dec; 6 Suppl J():J143-6. PubMed ID: 21930480
    [No Abstract]   [Full Text] [Related]  

  • 12. Stenting small vessels? Not a small issue.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):430-1. PubMed ID: 15274149
    [No Abstract]   [Full Text] [Related]  

  • 13. Device selection for percutaneous coronary intervention: The case is still open.
    Lemos PA
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):466. PubMed ID: 19235235
    [No Abstract]   [Full Text] [Related]  

  • 14. Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation.
    Gurbel PA; Bliden KP; Antonino MJ; Gesheff T; Cummings CC; Dubois BV; Herzog WR; Tantry US
    Thromb Res; 2012 Jan; 129(1):1-2. PubMed ID: 21862113
    [No Abstract]   [Full Text] [Related]  

  • 15. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 May; 77(6):773-4. PubMed ID: 21520379
    [No Abstract]   [Full Text] [Related]  

  • 16. Breakage of floppy wire during coronary stenting and long-term outcome.
    Ercan S; Davutoglu V; Ozer O
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):746. PubMed ID: 24569342
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining a new standard for IVUS optimized drug-eluting stent implantation--the PRAVIO study: do we know the right technique for stent optimization?
    Leesar MA
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):357-8. PubMed ID: 19642184
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
    Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
    JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting versus bare-metal stents: when and for whom?
    Beyar R; Nikolsky E
    J Invasive Cardiol; 2008 Mar; 20(3):105-6. PubMed ID: 18316824
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-eluting stent fracture and intramyocardial coronary course.
    Barbou F; Schiano P; Monsegu J
    Arch Cardiovasc Dis; 2011 Jan; 104(1):64-6. PubMed ID: 21276581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.